Adults are as likely as children to die from diseases that they can be immunized. For example, vaccination can prevent about 50% of deaths from pneumococcal disease and 80% of deaths from influenza-related complications in the elderly. Adult vaccines continues to be one of the growing segment for pharmaceutical companies. The adult vaccines market has been forecasted to increase at a compound annual growth rate (CAGR) of around 7% over the next five years. The driving factors for adult vaccines growth are an increasing acceptance of adult vaccines and the public health focus on flu prevention, as well as introductions of new vaccines. The vaccines industry also faces hindrances such as vaccine safety, shortages and delays, vaccine development time line as well as entry barriers for new manufacturers.
Browse the Full Report @ http://www.orbisresearch.com/reports/index/global-adult-vaccines-market-and-company-analysis-to-2020 .
The influenza vaccines are the most popular and accepted vaccination amongst adults. It accounted for maximum share of adult vaccines market in 2014. The vaccinations for hepatitis is the second most popular vaccines in 2014. The HPV/Cervical cancer vaccines and pneumococcal vaccines stands at third and fourth spots respectively in adult vaccines market. While vaccines for zoster shingles and DTP are also gaining ground in adult vaccines market landscape.
Check the Discount for this Report @ http://www.orbisresearch.com/contacts/discount/175258 .
In 2010, GSK was the leader in the adult vaccines market but it lost the leadership position to Merck. Sanofi Pasteur stands at the second spot in the adult vaccines market. GSK slipped to third position in the global adult vaccines market in 2014. While Pfizer and Novartis is at the fourth and fifth position respectively in the adult vaccines market landscape.
The 9 Diseases covered in the report are analyzed from four viewpoints:
1. Adult Vaccines Market (2007 – 2020)
2. Number of Adults Vaccinated (2007 – 2020)
3. Number of Doses (2007 – 2020)
4. Company Sales Share (2010 – 2020)
Request a Sample of this Report @ http://www.orbisresearch.com/contacts/request-sample/175258 .
Some Points from List Of Table :
Table 4-1: Global – Prostate Cancer Therapy Market Share (Percent), 2011 – 2014
Table 4-2: Global – Forecast for Prostate Cancer Therapy Market Share (Percent), 2015 – 2020
Table 4-3: Global – Prostate Cancer Drugs Market Share (Percent), 2011 – 2014
Table 4-4: Global – Forecast for Prostate Cancer Drugs Market Share (Percent), 2015 – 2020
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customised reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialisation. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +912064101019